Sofia Vaccarino Gearty, M.D.,Ph.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 1 | 2021 | 889 | 0.480 |
Why?
|
| Cholangiocarcinoma | 1 | 2019 | 516 | 0.470 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 570 | 0.440 |
Why?
|
| Stem Cells | 1 | 2021 | 3566 | 0.320 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4477 | 0.310 |
Why?
|
| Carcinoma | 1 | 2019 | 2375 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3338 | 0.290 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2021 | 73 | 0.210 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2021 | 143 | 0.200 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2021 | 147 | 0.200 |
Why?
|
| Clone Cells | 1 | 2021 | 1692 | 0.160 |
Why?
|
| Killer Cells, Natural | 2 | 2018 | 2131 | 0.150 |
Why?
|
| STAT1 Transcription Factor | 1 | 2018 | 320 | 0.150 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2019 | 340 | 0.130 |
Why?
|
| Staphylococcus epidermidis | 1 | 2015 | 117 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2021 | 2988 | 0.130 |
Why?
|
| Skin | 2 | 2021 | 4372 | 0.130 |
Why?
|
| Hepatitis B, Chronic | 1 | 2019 | 392 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1851 | 0.120 |
Why?
|
| Interferon-alpha | 1 | 2018 | 895 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2019 | 1041 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1620 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 2540 | 0.110 |
Why?
|
| Virus Diseases | 1 | 2018 | 711 | 0.100 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2177 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 3769 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3476 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2725 | 0.090 |
Why?
|
| Myeloid Cells | 1 | 2014 | 808 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2021 | 5021 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 1400 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12954 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4251 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18027 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2014 | 2961 | 0.050 |
Why?
|
| Mice | 4 | 2021 | 81154 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9239 | 0.050 |
Why?
|
| Immune Tolerance | 2 | 2021 | 2258 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2021 | 527 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2021 | 2008 | 0.030 |
Why?
|
| Animals | 4 | 2021 | 168660 | 0.030 |
Why?
|
| Leukemic Infiltration | 1 | 2014 | 48 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 2006 | 0.030 |
Why?
|
| Female | 2 | 2021 | 380020 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 21824 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 5524 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2015 | 1172 | 0.020 |
Why?
|
| Cell Movement | 1 | 2021 | 5216 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 1272 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 5881 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 1479 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14563 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2014 | 2378 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2021 | 19232 | 0.020 |
Why?
|
| Adult | 1 | 2019 | 213889 | 0.020 |
Why?
|
| Male | 1 | 2021 | 349776 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 18107 | 0.010 |
Why?
|
| Humans | 4 | 2021 | 743811 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 9731 | 0.010 |
Why?
|
| Inflammation | 1 | 2015 | 10629 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23398 | 0.010 |
Why?
|